India · Delayed Price · Currency is INR Remedium Lifecare Statistics
Total Valuation
BOM:539561 has a market cap or net worth of INR 387.07 million. The enterprise value is 11.25 billion.
| Market Cap | 387.07M |
| Enterprise Value | 11.25B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:539561 has 403.20 million shares outstanding. The number of shares has increased by 9.07% in one year.
| Current Share Class | 403.20M |
| Shares Outstanding | 403.20M |
| Shares Change (YoY) | +9.07% |
| Shares Change (QoQ) | -4.83% |
| Owned by Insiders (%) | 62.84% |
| Owned by Institutions (%) | 7.57% |
| Float | 65.09M |
Valuation Ratios
The trailing PE ratio is 5.13.
| PE Ratio | 5.13 |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 199.92, with an EV/FCF ratio of -1.12.
| EV / Earnings | 91.80 |
| EV / Sales | 2.14 |
| EV / EBITDA | 199.92 |
| EV / EBIT | 200.63 |
| EV / FCF | -1.12 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 10.34.
| Current Ratio | 1.07 |
| Quick Ratio | 0.44 |
| Debt / Equity | 10.34 |
| Debt / EBITDA | 193.28 |
| Debt / FCF | -1.08 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.22% and return on invested capital (ROIC) is 0.49%.
| Return on Equity (ROE) | 16.22% |
| Return on Assets (ROA) | 0.19% |
| Return on Invested Capital (ROIC) | 0.49% |
| Return on Capital Employed (ROCE) | 5.33% |
| Revenue Per Employee | 752.71M |
| Profits Per Employee | 17.51M |
| Employee Count | 7 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.81 |
Taxes
In the past 12 months, BOM:539561 has paid 35.54 million in taxes.
| Income Tax | 35.54M |
| Effective Tax Rate | 22.48% |
Stock Price Statistics
The stock price has decreased by -81.70% in the last 52 weeks. The beta is 1.38, so BOM:539561's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -81.70% |
| 50-Day Moving Average | 1.42 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 21.16 |
| Average Volume (20 Days) | 13,241,630 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539561 had revenue of INR 5.27 billion and earned 122.54 million in profits. Earnings per share was 0.19.
| Revenue | 5.27B |
| Gross Profit | 154.88M |
| Operating Income | 56.07M |
| Pretax Income | 158.08M |
| Net Income | 122.54M |
| EBITDA | 56.27M |
| EBIT | 56.07M |
| Earnings Per Share (EPS) | 0.19 |
Balance Sheet
The company has 13.16 million in cash and 10.88 billion in debt, giving a net cash position of -10.86 billion or -26.94 per share.
| Cash & Cash Equivalents | 13.16M |
| Total Debt | 10.88B |
| Net Cash | -10.86B |
| Net Cash Per Share | -26.94 |
| Equity (Book Value) | 1.05B |
| Book Value Per Share | 1.19 |
| Working Capital | 993.31M |
Cash Flow
In the last 12 months, operating cash flow was -9.98 billion and capital expenditures -58.24 million, giving a free cash flow of -10.04 billion.
| Operating Cash Flow | -9.98B |
| Capital Expenditures | -58.24M |
| Free Cash Flow | -10.04B |
| FCF Per Share | -24.91 |
Margins
Gross margin is 2.94%, with operating and profit margins of 1.06% and 2.33%.
| Gross Margin | 2.94% |
| Operating Margin | 1.06% |
| Pretax Margin | 3.00% |
| Profit Margin | 2.33% |
| EBITDA Margin | 1.07% |
| EBIT Margin | 1.06% |
| FCF Margin | n/a |
Dividends & Yields
BOM:539561 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.07% |
| Shareholder Yield | -9.07% |
| Earnings Yield | 31.66% |
| FCF Yield | -2,594.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 5, 2024. It was a forward split with a ratio of 4.
| Last Split Date | Jul 5, 2024 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
BOM:539561 has an Altman Z-Score of 0.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.48 |
| Piotroski F-Score | 4 |